These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35638299)

  • 21. Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.
    Mateus J; Grifoni A; Voic H; Angelo MA; Phillips E; Mallal S; Sidney J; Sette A; Weiskopf D
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33198381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
    de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
    Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
    J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.
    Kwallah Ao; Inoue S; Thairu-Muigai AW; Kuttoh N; Morita K; Mwau M
    Jpn J Infect Dis; 2015; 68(3):230-4. PubMed ID: 25672346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
    Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
    PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
    Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
    Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.
    Engelmann F; Josset L; Girke T; Park B; Barron A; Dewane J; Hammarlund E; Lewis A; Axthelm MK; Slifka MK; Messaoudi I
    PLoS Negl Trop Dis; 2014; 8(11):e3295. PubMed ID: 25412185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of yellow fever.
    Monath TP
    Antiviral Res; 2008 Apr; 78(1):116-24. PubMed ID: 18061688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a reporter yellow fever virus for high throughput antiviral assays.
    Sanchez-Velazquez R; de Lorenzo G; Tandavanitj R; Setthapramote C; Bredenbeek PJ; Bozzacco L; MacDonald MR; Clark JJ; Rice CM; Patel AH; Kohl A; Varjak M
    Antiviral Res; 2020 Nov; 183():104939. PubMed ID: 32980446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.
    Thibodeaux BA; Garbino NC; Liss NM; Piper J; Blair CD; Roehrig JT
    Vaccine; 2012 May; 30(21):3180-7. PubMed ID: 22425792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A basic cluster in the N terminus of yellow fever virus NS2A contributes to infectious particle production.
    Voßmann S; Wieseler J; Kerber R; Kümmerer BM
    J Virol; 2015 May; 89(9):4951-65. PubMed ID: 25694595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
    Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
    Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
    Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
    Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of NS5 Protein in Determination of Host Cell Range for Yellow Fever Virus.
    Laurent-Rolle M; Morrison J
    DNA Cell Biol; 2019 Dec; 38(12):1414-1417. PubMed ID: 31633391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental therapies for yellow fever.
    Julander JG
    Antiviral Res; 2013 Feb; 97(2):169-79. PubMed ID: 23237991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
    Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
    Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of a method for detection of specific antibodies to E protein of yellow fever virus (Flaviviridae: Flavivirus) by enzyme immunoassay].
    Krivosheina EI; Kartashov MY; Naidenova EV; Ushkalenko ND; Pyankov SA; Ternovoi VA; Loktev VB
    Vopr Virusol; 2022 Sep; 67(4):341-450. PubMed ID: 36097715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.
    Neyts J; Meerbach A; McKenna P; De Clercq E
    Antiviral Res; 1996 May; 30(2-3):125-32. PubMed ID: 8783804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.